IKON Group Investments — Global Holdings Company

IKON Market Brief: Free research hub Nila aims to demystify menopause, other hormone conditions

Posted by:

|

On:

|

Nila’s goal is to offer inclusive information to underrepresented communities like neurodivergent or transgender people.

Source: www.fiercehealthcare.com

IKON Portfolio Context

Kynetide Peptides supplies 99%+ HPLC-verified research compounds with batch-specific COAs to 2,400+ researchers worldwide.

Posted by

in